Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
187M
-
Number of holders
-
25
-
Total shares
-
965K
-
Shares change
-
+965K
-
Total reported value, excl. options
-
$1.52M
-
Value change
-
+$1.52M
-
Number of buys
-
24
-
Price
-
$1.58
Significant Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) as of Q2 2023
24 filings reported holding TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock as of Q2 2023.
Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP) has 25 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 965K shares
of 187M outstanding shares and own 0.52% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (399K shares), RENAISSANCE TECHNOLOGIES LLC (211K shares), GEODE CAPITAL MANAGEMENT, LLC (85.4K shares), ACADIAN ASSET MANAGEMENT LLC (68.7K shares), RAYMOND JAMES & ASSOCIATES (44.4K shares), JPMORGAN CHASE & CO (32.9K shares), STATE STREET CORP (31.2K shares), BANK OF AMERICA CORP /DE/ (26.4K shares), TWO SIGMA SECURITIES, LLC (24.8K shares), and NORTHERN TRUST CORP (16.3K shares).
This table shows the top 25 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.